BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR CONTROLLING CHOLESTEROL LEVELS
申请人:Whiteford Jeffery A.
公开号:US20100016270A1
公开(公告)日:2010-01-21
A pharmaceutically active agent, a pharmaceutically active agent carrier and method of use thereof are described. In some embodiments, a system may include a composition. The composition may include one or more bridged polycyclic compounds. At least one of the bridged polycyclic compounds may include at least two cyclic groups, and at least two pharmaceutically active agents may be associated with the bridged polycyclic compound. In some embodiments, one or more bridged polycyclic compounds may be administered to a subject to improve cardiac and/or cardiovascular health. In some embodiments, one or more bridged polycyclic compounds may be administered to a subject to control cholesterol levels.
本文描述了一种药理活性剂、药理活性剂载体及其使用方法。在某些实施例中,该系统可能包括一种组合物。该组合物可能包括一个或多个桥接多环化合物。其中至少一个桥接多环化合物可能包括至少两个环状基团,并且至少有两种药理活性剂可能与桥接多环化合物相关联。在某些实施例中,可以向受试者施用一个或多个桥接多环化合物以改善心脏和/或心血管健康。在某些实施例中,可以向受试者施用一个或多个桥接多环化合物以控制胆固醇水平。